Day: December 1, 2023
New Location Highlights Ongoing Global Expansion InitiativesReborn Coffee Kuala Lumpur, MalaysiaReborn Coffee Kuala Lumpur, MalaysiaBREA, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) — Reborn Coffee, Inc. (NASDAQ: REBN) (“Reborn”, or the “Company”), a California-based retailer of specialty coffee, today announced the grand opening of a new flagship store under the newly incorporated Reborn Coffee Malaysia, at the Exchange TRX mall in Kuala Lumpur, Malaysia.
The Exchange TRX is a 17-acre integrated development set to become one of Asia’s leading lifestyle hubs, including world class shopping and dining, residential homes and office spaces. The flagship store at the Exchange TRX mall will be located adjacent to other global brands including Apple and Shake Shack. The location is being spearheaded by Barrie...
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting
Written by Customer Service on . Posted in Public Companies.
MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Amy Chappell, M.D., FAAN, will be presenting preclinical in vivo data evaluating BAER-101 using the SynapCell’s Genetic Absence Epilepsy Rat from Strasbourg (“GAERS”) model of absence epilepsy at the American Epilepsy Society (AES) 2023 Annual Meeting in Orlando, FL on December 2, 2023.
The Company’s presentation details are as follows:
Title: A Phase 2- Ready Potentiator of α2/3-Containing GABAA Receptors Potently and Fully Blocks Seizures in Rats with Genetic Absence EpilepsyPoster Session and Location: Session 1; West Hall C, Level 2Session Date/Time:...
Xcel Brands, Inc. to Present at Upcoming Investor Conferences
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with significant expertise in livestream shopping and social commerce, today announced that it is scheduled to present at the following investor conferences:
Noble Capital Markets 19th Annual Emerging Growth Equity Conference Location: Boca Raton, FLDate: December 4 – 5, 2023Presentation Time: December 5 at 3:00 pm ETWebcast: www.nobleconference.com
Sidoti Small-Cap Virtual ConferenceLocation: VirtualDate: December 6 – 7, 2023Presentation Time: December 6 at 1:00 pm ETWebcast: https://sidoti.zoom.us/webinar/register/WN_QIGTd7obSLSOIBUV8y5tZg#/registration
Robert W. D’Loren, Chairman and Chief Executive Officer of Xcel Brands, will be leading the formal presentation and answering questions...
Worthington Enterprises Completes Separation of Worthington Steel
Written by Customer Service on . Posted in Mergers And Acquisitions.
COLUMBUS, Ohio, Dec. 01, 2023 (GLOBE NEWSWIRE) — Worthington Enterprises, Inc. (NYSE: WOR) formerly Worthington Industries, Inc., a leading industrial manufacturing company, today completed the previously announced separation of its Steel Processing business, Worthington Steel, Inc., into a standalone, publicly traded company. Worthington Steel common stock begins “regular-way” trading on the New York Stock Exchange (NYSE) today under the ticker symbol “WS”. Worthington Enterprises common stock continues trading on the NYSE under the ticker symbol “WOR”.
Andy Rose, president and chief executive officer, Worthington Enterprises, said, “Today is a major milestone in Worthington’s history. As separate companies, both Worthington Enterprises and Worthington Steel will be better able to serve their respective customers, deliver on their...
Bitfarms Earns 392 BTC in November 2023
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
– Miners purchased for H1 2024 upgrade plan to 12 MW –– Increases hashrate 2% in the month to 6.4 EH/s –– Finalizing contract to increase Paso Pe, Paraguay from 50 MW to 70 MW –
TORONTO, Ontario and BROSSARD, Québec, Dec. 01, 2023 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ: BITF//TSX: BITF), a global vertically integrated Bitcoin mining company, provides a monthly update for November 2023.
“In November, we delivered solid performance in the face of network difficulty increases from more miners coming online going into the 2024 Halving and, in anticipation of the Halving, we initiated our 2024 transformative fleet upgrade plan. We placed a firm purchase order for 35,888 high-performance Bitmain T21 miners, which are scheduled for deliveries from March 2024 to May 2024,” said Geoff Morphy, CEO of Bitfarms....
Annovis Bio Appoints Andrew Walsh as Vice President Finance
Written by Customer Service on . Posted in Public Companies.
BERWYN, Pa., Dec. 01, 2023 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s disease (PD) today announced the appointment of Andrew Walsh as VP, Finance.
“We remain steadfast in advancing our lead candidate buntanetap, as we gear up to receive pivotal data from both our Alzheimer’s and Parkinson’s clinical trials in 2024. The addition of Andrew Walsh to our team marks another step in our growth plans,” said Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis. “Andrew brings 12 years of extensive experience in finance operations, adding a significant layer of strength that will be integral to the company’s continued success.”
“I am thrilled with my...
HydroGraph Announces Closing of First Tranche of Private Placement
Written by Customer Service on . Posted in Public Companies.
Not for distribution to U.S. newswire services or dissemination in the United States
VANCOUVER, British Columbia, Dec. 01, 2023 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGCPF) (the “Company” or “HydroGraph”) is pleased to announce that the Company has completed the first tranche of its non-brokered private placement (the “Offering”) previously announced on October 30, 2023. Pursuant to the first tranche of the Offering, the Company issued an aggregate of 10,260,856 units of the Company (the “Units”) for aggregate gross proceeds of approximately C$1.03 million. The Units were offered in US dollars and Canadian dollars at the respective prices of US$0.074 and C$0.10. The majority of the proceeds were provided by new US-based subscribers but also included an investment by Gulf Cryo, LLC, a major industrial...
Platinex Announces Increased Flow Through Financing and Receipt of Study Results on the W2 Copper-Nickel-PGE Project in Northern Ontario
Written by Customer Service on . Posted in Public Companies.
TORONTO, Dec. 01, 2023 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) is pleased to announce that the Company has increased its previously announced flow through financing (see press release dated Nov 27, 2023) to $1,500,000 (“the FT Offering”). The flow through common shares are priced at C$0.04 per share (“FT common share”). Each FT common share consists of one common share of the Company. The closing of this final tranche of the FT Offering is underway and is expected to be completed shortly.
The Company will use the gross proceeds of the FT Offering to incur eligible Canadian exploration expenses that are “flow-through critical mineral mining expenditures” and will qualify as flow-through mining expenditure as such terms are defined in the Income Tax Act (Canada) related...
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
Written by Customer Service on . Posted in Public Companies.
Posters with new preclinical data on the pharmacokinetic and pharmacodynamic behavior of OV329 support its profile as a potential best-in-class GABA aminotransferase inhibitor
Disease models provide further evidence characterizing OV350 and its anticipated seizure reduction and neuroprotective profile, including its ability to reverse diazepam-resistant seizuresNEW YORK, Dec. 01, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by brain disorders, today announced that five posters featuring data supporting its OV329 and OV350 programs for the potential treatment of epilepsies and treatment-resistant seizures will be presented at the 2023 American Epilepsy Society (AES) Annual Meeting...
Brixton Metals Drills 76.50m of 1.08 g/t Gold within 179.50m of 0.51 g/t Gold and 54.00m of 1.03 g/t Gold within 149.00m of 0.55 g/t Gold at its Trapper Target on the Thorn Project
Written by Customer Service on . Posted in Public Companies.
Figure 1https://brixtonmetals.com/wp-content/uploads/2023/11/Figure-1_1Dec2023.jpegFigure 2https://brixtonmetals.com/wp-content/uploads/2023/11/Figure-2_1Dec2023.jpegFigure 3https://brixtonmetals.com/wp-content/uploads/2023/11/Figure-3_1Dec2023-scaled.jpgFigure 4https://brixtonmetals.com/wp-content/uploads/2023/11/image.pngFigure 5https://brixtonmetals.com/wp-content/uploads/2023/11/Figure-5_1Dec2023.jpegVANCOUVER, British Columbia, Dec. 01, 2023 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce the final batch of 2023 drill results from the Trapper Gold Target at its wholly owned Thorn Project. The project is located in Northwest British Columbia, 90km east of Juneau, Alaska and within the Taku River Tlingit...